Mayuko Miyamoto

886 total citations
16 papers, 707 citations indexed

About

Mayuko Miyamoto is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Mayuko Miyamoto has authored 16 papers receiving a total of 707 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Cancer Research and 2 papers in Oncology. Recurrent topics in Mayuko Miyamoto's work include MicroRNA in disease regulation (8 papers), Circular RNAs in diseases (6 papers) and Extracellular vesicles in disease (4 papers). Mayuko Miyamoto is often cited by papers focused on MicroRNA in disease regulation (8 papers), Circular RNAs in diseases (6 papers) and Extracellular vesicles in disease (4 papers). Mayuko Miyamoto collaborates with scholars based in Japan and United States. Mayuko Miyamoto's co-authors include T. Iwahara, Yoshinori Harada, Yoshiharu Takemitsu, Kenjiro Sawada, Tadashi Kimura, Masaki Kobayashi, Koji Nakamura, Kae Hashimoto, Yasuto Kinose and Aasa Shimizu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Scientific Reports.

In The Last Decade

Mayuko Miyamoto

16 papers receiving 695 citations

Peers

Mayuko Miyamoto
Yazeng Huang China
Zhaohui Lyu China
Yun Zuo China
Sayumi Higashi Japan
Zeran Yang China
Johann Gout Germany
Haiyu Shao China
Mingtian Wei China
Yazeng Huang China
Mayuko Miyamoto
Citations per year, relative to Mayuko Miyamoto Mayuko Miyamoto (= 1×) peers Yazeng Huang

Countries citing papers authored by Mayuko Miyamoto

Since Specialization
Citations

This map shows the geographic impact of Mayuko Miyamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mayuko Miyamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mayuko Miyamoto more than expected).

Fields of papers citing papers by Mayuko Miyamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mayuko Miyamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mayuko Miyamoto. The network helps show where Mayuko Miyamoto may publish in the future.

Co-authorship network of co-authors of Mayuko Miyamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Mayuko Miyamoto. A scholar is included among the top collaborators of Mayuko Miyamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mayuko Miyamoto. Mayuko Miyamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Sawada, Kenjiro, Mayuko Miyamoto, Aska Toda, et al.. (2023). Continuous Administration of Anti-VEGFA Antibody Upregulates PAI-1 Secretion from Ovarian Cancer Cells via miR-143-3p Downregulation. Molecular Cancer Research. 21(10). 1093–1106. 9 indexed citations
2.
3.
Miyamoto, Mayuko, Kenjiro Sawada, Koji Nakamura, et al.. (2020). Paclitaxel exposure downregulates miR-522 expression and its downregulation induces paclitaxel resistance in ovarian cancer cells. Scientific Reports. 10(1). 16755–16755. 16 indexed citations
4.
Kobayashi, Masaki, Kenjiro Sawada, Mayuko Miyamoto, et al.. (2020). Exploring the potential of engineered exosomes as delivery systems for tumor-suppressor microRNA replacement therapy in ovarian cancer. Biochemical and Biophysical Research Communications. 527(1). 153–161. 90 indexed citations
5.
Kobayashi, Masaki, Kenjiro Sawada, Akihiko Yoshimura, et al.. (2020). Clinical effects of switching from minodronate to denosumab treatment in patients with postmenopausal osteoporosis: a retrospective study. BMC Women s Health. 20(1). 48–48. 5 indexed citations
6.
Nakamura, Koji, Kenjiro Sawada, Mayuko Miyamoto, et al.. (2019). Downregulation of miR-194-5p induces paclitaxel resistance in ovarian cancer cells by altering MDM2 expression. Oncotarget. 10(6). 673–683. 31 indexed citations
7.
Nakamura, Koji, Kenjiro Sawada, Masaki Kobayashi, et al.. (2019). Role of the Exosome in Ovarian Cancer Progression and Its Potential as a Therapeutic Target. Cancers. 11(8). 1147–1147. 62 indexed citations
8.
9.
Kobayashi, Masaki, Kenjiro Sawada, Akihiko Yoshimura, et al.. (2018). Abstract 5408: Elevated level of serum miR-1290 is correlated with high-grade serous ovarian epithelial ovarian cancer and might be a potential biomarker. Cancer Research. 78(13_Supplement). 5408–5408. 1 indexed citations
10.
Kobayashi, Masaki, Kenjiro Sawada, Koji Nakamura, et al.. (2018). Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types. Journal of Ovarian Research. 11(1). 74 indexed citations
11.
Toda, Aska, Kenjiro Sawada, Akihiko Yoshimura, et al.. (2017). Effects of minodronate in postmenopausal women with osteoporosis who received prior treatment with raloxifene. International Journal of Women s Health. Volume 9. 821–825. 1 indexed citations
12.
Miyamoto, Mayuko, et al.. (2013). Spontaneous Uterine Rupture at 15 Weeks' Gestation in a Patient with a History of Cesarean Delivery after Removal of Shirodkar Cerclage. SHILAP Revista de lepidopterología. 4(1). 1–4. 6 indexed citations
13.
Yamagami, Keiko, M Hosoi, Tohru Yamamoto, et al.. (2004). Coronary arterial calcification is associated with albuminuria in type 2 diabetic patient. Diabetes Obesity and Metabolism. 7(4). 390–396. 12 indexed citations
14.
Minamiyama, Yukiko, et al.. (1996). Dynamic aspects of glutathione and nitric oxide metabolism in endotoxemic rats. American Journal of Physiology-Gastrointestinal and Liver Physiology. 271(4). G575–G581. 21 indexed citations
15.
Ogawa, Hiroyasu, Masaki Inoue, Osamu Tanizawa, Mayuko Miyamoto, & Masami Sakurai. (1992). Altered expression of sialyl-Tn, Lewis antigens and carcinoembryonic antigen between primary and metastatic lesions of uterine cervical cancers. Histochemistry and Cell Biology. 97(4). 311–317. 21 indexed citations
16.
Takemitsu, Yoshiharu, et al.. (1988). Lumbar degenerative kyphosis. Clinical, radiological and epidemiological studies.. PubMed. 13(11). 1317–26. 242 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yazeng Huang Breakdown of academic impact, for papers by Zhaohui Lyu Breakdown of academic impact, for papers by Yun Zuo Breakdown of academic impact, for papers by Sayumi Higashi Breakdown of academic impact, for papers by Zeran Yang Breakdown of academic impact, for papers by Johann Gout Breakdown of academic impact, for papers by Haiyu Shao Breakdown of academic impact, for papers by Mingtian Wei
Rankless by CCL
2026